FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma By Ogkologos - April 1, 2026 241 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study CA209-8UT (SWOG 1826) Source RELATED ARTICLESMORE FROM AUTHOR Two novel bispecific antibodies in combination with chemotherapy show efficacy in neuroendocrine carcinomas Sacituzumab tirumotecan plus pembrolizumab significantly prolongs progression-free survival in advanced non-small cell lung cancer Adding Abiraterone to ADT and Docetaxel Improves Survival in Metastatic Prostate Cancer MOST POPULAR How to Spend Time with Friends and Family Now that COVID... August 13, 2020 Jiffy Lube Surprises Volunteer Who Drives Cancer Patients To Treatment With... December 11, 2019 FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer January 17, 2025 Cincinnati Police Are Wearing Pink Badges For Breast Cancer Awareness September 24, 2019 Load more HOT NEWS EMA Recommends Extending Indications for Pembrolizumab to Include Adjuvant Treatment in... Asciminib Shows Superior Efficacy Over Investigator-Selected TKIs and Imatinib in Patients... Julia Louis-Dreyfus Talks About The Side Effects of Chemotherapy Elliot Colburn MP: Why Cancer Research UK’s Manifesto for Cancer Research...
